Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block in Obstructive Sleep Apnea
NCT06249490Recruiting
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in obstructive sleep apnea (OSA) (2 arms). Primary endpoint: Epworth Sleepiness Scale at day 20. Started Feb 2024; status: recruiting.
02
Drugs
lidocaine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06249490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06249490.